Zovighian Bernard J 的 Form 4 申報
Edwards Lifesciences CorpEW，2026/5/12 申報
- 申報編號
- 0001225208-26-005172
- 申報時間
- 2026/5/12
- 交易日
- 2026/5/11-5/12
- 申報延遲
- 1 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易、1 筆衍生性交易。公開市場賣出合計 $283.3 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Zovighian Bernard JCIK 0001665141 | 董事、高階主管（執行長） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/5/11 | Common Stock | M行使選擇權取得 | +47,207 | $0.00F1 | $0 | 157,491.65 | 直接 | |
| 2026/5/11 | Common Stock | F扣股繳稅處分 | −26,198 | $79.96 | −$2,094,792.08 | 125,804.65 | 直接 | |
| 2026/5/12 | Common Stock | G贈與處分 | −26,640 | $0.00 | $0 | 99,164.65 | 直接 | |
| 2026/5/12 | Common Stock | G贈與取得 | +26,640 | $0.00 | $0 | 48,390.55 | 間接 | |
| 2026/5/12 | Common Stock | S賣出處分 | −845 | $78.40F3 | −$66,248 | 47,545.55 | 間接 | |
| 2026/5/12 | Common Stock | S賣出處分 | −35,506 | $77.92F4 | −$2,766,627.52 | 12,039.55 | 間接 |
衍生性證券（表 II）
選擇權、認股權證、限制型股票單位等。股數是標的股票的股數；單價與金額是衍生證券本身的價格，交易後持有是衍生證券的單位數。
| 交易日 | 證券 | 交易 | 標的股數 | 單價 | 金額 | 交易後持有 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2026/5/11 | Common Stock | M行使選擇權處分 | −47,207 | $0.00 | $0 | 0 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4.
表 I 有 1 筆交易的價格引用這則附註。
- F3
This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
- F4
This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
表 I 有 1 筆交易的價格引用這則附註。
備註
This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.